Production (Stage)
Rani Therapeutics Holdings, Inc.
RANI
$0.5289
-$0.031-5.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.92% | 11.63% | 21.00% | 11.14% | -1.05% |
| Total Depreciation and Amortization | 16.89% | 25.06% | 28.61% | 36.99% | 41.12% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 20.21% | 71.85% |
| Total Other Non-Cash Items | 73.30% | 61.72% | 44.51% | 23.70% | 11.28% |
| Change in Net Operating Assets | -17.17% | 74.58% | -214.81% | -477.43% | -334.24% |
| Cash from Operations | 29.37% | 30.72% | 26.35% | 11.84% | 1.67% |
| Capital Expenditure | 69.87% | 78.19% | 74.62% | 51.69% | 38.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.26% | -35.42% | 74.74% | 165.10% | 155.73% |
| Cash from Investing | -23.00% | -33.66% | 89.48% | 162.44% | 152.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,731.51% | 4,616.96% | 2,115.64% | -5.93% | -14.48% |
| Repurchase of Common Stock | -84.21% | 70.99% | 76.54% | 93.02% | 94.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,713.01% | 5,730.47% | -46.29% | -98.60% | -98.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.71% | 90.06% | 96.88% | 96.59% | 86.30% |